Self-expanding valves, a history of stroke, renal dysfunction and nontransfemoral access were all linked to an increased risk ...
A systematic review of nine hospital-based studies finds that penicillin allergy delabeling interventions appear safe and ...
A new review argues that moderate aortic stenosis is a heterogeneous, high-risk condition that standard echocardiography ...
RELATIVITY-047's 5-year survival data and LAG-3-high CD8+ T cell biomarker findings signal a shift in how immuno-oncology ...
In rare diseases and narrowly defined populations, recruiting both investigational and control arms can take years, and ...
Acute kidney injury (AKI) affects ∼20% of hospitalized patients and is traditionally viewed as a transient complication of acute illness. Evidence suggests that AKI can initiate long-term renal and ...
The European Medicines Agency (EMA) is holding a consultation into the methodological aspects of confirmatory platform ...
Accelerated approval is supported by 34-week interim data from the phase 3 I CAN trial showing a statistically significant 43% placebo-adjusted reduction in proteinuria.
PRI analysis shows Alzheimer’s biomarkers like Amyloid PET and plasma p-tau217 are driving earlier, precise diagnosis and ...
Alzheimer’s Blood Test Market to grow from USD 284.6 Mn in 2026 to USD 2593.9 Mn by 2036 at a 24.7% CAGR. Get segment, region & competitor insights.
Post-Discharge Antiseizure Medication Use and Poststroke Survival: An Emulated Target Trial in Older Adults [RCT emulation study] In patients hospitalized for acute ischemic stroke who initiated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results